Lung Cancer News and Research

Latest Lung Cancer News and Research

Major trial to test new surgical approach for patients with lung cancer

The University of Montreal Hospital Research Centre is launching a major international clinical trial to test a minimally invasive and safer surgical approach for patients with lung cancer: video-assisted thoracoscopic (VATS) lobectomy with ultrasonic pulmonary artery sealing.

11 Jul 2016

UCLA researchers develop new combination therapy to activate immune response against glioblastoma

UCLA researchers have developed a new breakthrough combination treatment that utilizes a vaccine to activate an immune response against advanced brain tumors.

8 Jul 2016

Imaging technique could help doctors identify patients who may benefit breast cancer treatment

Cancer Research UK scientists have used imaging techniques as a new way to identify patients who could benefit from certain breast cancer treatments, according to a study published in ONCOTARGET today, (Thursday).

8 Jul 2016

New microfluidic device allows scientists to use safe electric fields to treat cancer

Researchers at MIT's research center in Singapore have developed a new microfluidic device that tests the effects of electric fields on cancer cells.

7 Jul 2016

Necitumumab drug shows minor added benefit in patients with metastatic NSCLC

The monoclonal antibody necitumumab has been approved since February 2016 for the treatment of patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) expressing non-small cell lung cancer (NSCLC) who have not received prior chemotherapy for this condition.

5 Jul 2016

British Lung Foundation launches exhibition at the houses of parliament

A week-long parliamentary exhibition is being held by the British Lung Foundation (BLF) in the Upper Waiting Hall at the houses of parliament from 4-8 July.

From Asthma + Lung UK 5 Jul 2016

Annual repeat CT scans can eliminate need for biopsy or surgery in NSNs

Annual low-dose computed-tomography (CT) screening can eliminate the need for biopsy or surgery in nonsolid lung nodules, according to a new study published online in the journal Radiology.

5 Jul 2016

First-line nivolumab promising in advanced NSCLC

Phase I results published in the Journal of Clinical Oncology suggest that nivolumab, either given alone or alongside platinum-based doublet chemotherapy, could have a role in the first-line treatment of advanced non-small-cell lung cancer.

5 Jul 2016

Immunotherapy in conjunction with drugs could be effective in treating pancreatic cancer

While immune therapy has proven effective in treating certain types of cancer, especially lung cancer and melanoma, tumors of the pancreas remain among the most difficult to treat and, so far, are impervious to immune-based therapies.

4 Jul 2016

Advances in inhaled drug delivery: an interview with Dr Robert Clarke

Delivering drugs to the lungs via inhalation has a number of potential advantages over traditional routes of administration like pills or injections. For treating pulmonary diseases, the obvious logic we are applying is topical delivery to the airways via inhalation.

1 Jul 2016

ALK fusion variants could influence NSCLC crizotinib response

In non-small-cell lung cancer patients with anaplastic lymphoma kinase rearrangement treated with crizotinib, progression-free survival varies according to the ALK fusion variant.

1 Jul 2016

Immunotherapy-treated cancer patients may develop rheumatic disorders

Oncologists need to be aware of the potential for rheumatological diseases in patients with cancer following treatment with immune checkpoint inhibitors, say US investigators.

30 Jun 2016

Siemens Healthineers' new CT and MRI technologies to aid research across various common clinical pathways

The Transforming Outcomes and Health Economics Through Imaging (TOHETI) programme is looking to change the way medical imaging works by undertaking a range of pioneering research.

24 Jun 2016

Yale-led study shows how EGFR silences tumor suppressor genes

A Yale-led study describes how a known cancer gene, EGFR, silences genes that typically suppress tumors. The finding, published in Cell Reports, may lead to the development of more effective, individualized treatment for patients with lung cancer and other cancer types.

24 Jun 2016

Taking ipilimumab, nivolumab drugs may increase risk of developing rheumatologic diseases

Case reports on 13 cancer patients suggest that a small number of cancer patients taking the immunotherapy drugs ipilimumab and nivolumab may be at some higher-than-normal risk of developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a preliminary study by Johns Hopkins Medicine researchers.

24 Jun 2016

Adherence to cancer prevention guidelines on diet and physical activity may reduce disease incidence

"Behaviors such as poor diet choices, physical inactivity, excess alcohol consumption and unhealthy body weight could account for more than 20 percent of cancer cases, and could, therefore, be prevented with lifestyle modifications," Kohler said, adding that when tobacco exposure is considered, these modifiable issues are believed to be factors in two-thirds of U.S. cancer deaths.

23 Jun 2016

Lung Cancer News and Research

Latest Lung Cancer News and Research

Major trial to test new surgical approach for patients with lung cancer

UCLA researchers develop new combination therapy to activate immune response against glioblastoma

Imaging technique could help doctors identify patients who may benefit breast cancer treatment

New microfluidic device allows scientists to use safe electric fields to treat cancer

Necitumumab drug shows minor added benefit in patients with metastatic NSCLC

British Lung Foundation launches exhibition at the houses of parliament

Annual repeat CT scans can eliminate need for biopsy or surgery in NSNs

First-line nivolumab promising in advanced NSCLC

Immunotherapy in conjunction with drugs could be effective in treating pancreatic cancer

Advances in inhaled drug delivery: an interview with Dr Robert Clarke

ALK fusion variants could influence NSCLC crizotinib response

Immunotherapy-treated cancer patients may develop rheumatic disorders

Siemens Healthineers' new CT and MRI technologies to aid research across various common clinical pathways

Yale-led study shows how EGFR silences tumor suppressor genes

Taking ipilimumab, nivolumab drugs may increase risk of developing rheumatologic diseases

Adherence to cancer prevention guidelines on diet and physical activity may reduce disease incidence

Novel combination therapy slows cancer growth in patients with advanced solid tumors

Researchers seek to develop novel antibody to treat glioblastoma

Study ignores possibility that drugs, chemicals affect sexes differently

Immunotherapy drugs given after chemotherapy may benefit ovarian cancer patients

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in